Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 5, 1996, Pages 611-620

  Wu, Ya Ping ^c   Van Breugel, Hans H F I ^c   Lankhof, Hanneke ^c   Wise, Robert J ^a   Handin, Robert I ^a   De Groot, Philip G ^c   Sixma, Jan J ^b  

^a Department of Internal Medicine   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NONE

Author keywords

adhesion; collagen type III; platelet; Von Willebrand factor

Indexed keywords

COLLAGEN TYPE 3; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; HEPARIN; MONOCLONAL ANTIBODY; PROSTACYCLIN; VON WILLEBRAND FACTOR;

ARTICLE; CONTROLLED STUDY; HEMOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; THROMBOCYTE ADHESION; THROMBOSIS;

EID: 0029876909     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.5.611     Document Type: Article

References (56)

1. Tschopp TB, Weiss HJ, Baumgartner HR. Decreased adhesion of platelets to subendothelium in von Willchrand's disease. J Lab Clin Med. 1974;83:296-300.
2. Weiss HJ, Baumgartner HR, Tschopp TB, Turilto VT, Cohen D. Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand's disease. Blood. 1978;51: 267-279.
3. Baumgartner HR, Tschopp TB, Meyer D. Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor. Brit J Haematol. 1980;44:127-139.
4. Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature. 1979;279: 635-638.
5. Stel HV, Sakariassen KS, De Groot PG, Van Mourik JA, Sixma JJ. Von Willebrand factor in the vessel wall mediates platelet adherence. Blood. 1985;65:85-90.
6. Turitto VT, Weiss HJ, Zimmerman TS, Sussman II. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood. 1985;65:823-831.
7. Fressinaud E, Baruch D, Rothschild C, Baumgartner HR, Meyer D. Platelet von Willebrand factor: evidence for its involvement in platelet adhesion to collagen. Blood. 1987;70:1214-1217.
8. D'Alessio P, Zwaginga JJ, de Boer HC, Federici AB, Rodeghiero F, Castaman G, Mariani G, Mannucci PM, de Groot PG, Sixma JJ. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor. Thromb Haemost. 1990;64:227-231.
9. Houdijk WPM, Sakariassen KS, Nievelstein PFEM, Sixma JJ. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar collagen types I and III. J Clin Invest. 1985;75:531-540.
10. Hantgan RR, Hindriks G, Taylor R, Sixma JJ, De Groot PG. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood. 1990;76:345-353.
11. Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function through adhesion receptors: a dual role for glycoprotein IIb-IIIa (integrin αIIbβ3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem. 1992;267:11300-11306.
12. Olson JD, Zaleski A, Herrmann D, Flood PA. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin. J Lab Clin Med. 1989; 114:6-18.
13. Danton MC, Zaleski A, Nichols WL, Olson JD. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor. J Lab Clin Med. 1994;124:274-282.
14. Doucet-de Bruine MHM, Sixma JJ, Over J, Beeser-Visser NH. Heterogeneity of factor VIII: characterization of forms of factor VIII binding to platelets in the presence of ristocetin. J Lab Clin Med. 1978;92:96-107.
15. Santoro SA. Preferential binding of high molecular weight forms of von Willebrand factor to fibrillar collagen. Biochim Biophys Acta. 1983;756:123-126.
16. Kessler CM, Floyd CM, Rick ME, Krizek DM, Lee SL, Gralnick HR. Collagen-factor VII/von Willebrand factor protein interaction. Blood. 1984;63:1291-1298.
17. Sixma JJ, Sakariassen KS, Beeser-Visser NH, Ottenhof-Rovers M, Bolhuis PA. Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various rnultimeric compositions. Blood. 1984;63:128-139.
18. Sakariassen KS, Fressinaud E, Girma JP, Baumgartner HR, Meyer D. Mediation of platelet adhesion to fibrillar collagen in flowing blood by a proteolytic fragment of human von Willebrand factor. Blood. 1986;67:1515-1518.
19. Berndt MC, Du X, Booth WJ. Ristocetin dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane GPIb-IX complex. Biochemistry. 1988;27:633-640.
20. Tettero PAT, Lansdorp PM, Leeksma OC, von dem Borne AEG. Monoclonal antibodies against human platelet glycoprotein IIIa. Br J Haematol. 1983;55:509-522.
21. Van Mourik JA, Mochtar IA. Purification of human anti-hemophilic factor (factor VIII) by gel-chromatography. Biochim Biophys Acta. 1970;221:677-679.
22. Lawrie AS, Hoser MJ, Savidge GF. Phast assessment of vWF:Ag multimeric distribution. Thromb Res. 1990;59:369-372.
23. Wise RJ, Pittman DD, Handin RI, Kaufman RJ, Orkin SH. The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell. 1988;52:229-236.
24. Wise RJ, Dorner AD, Krane M, Pitmann DD, Kaufman RJ. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem. 1991;266: 21948-21955.
25. Muggli R, Baumgartner HR, Tschopp TB, Keller H. Automated microdensitometry and protein assay as a measure for platelet adhesion and aggregation on collagen-coated slides under controlled flow conditions. J Lab Clin Med. 1980;95:195-207.
26. 1-integrin). Blood. 1994;83:1244-1250.
27. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52: 2745-2756.
28. Willems C, Astaldi GC, De Groot PG, Janssen MC, Gonsalvez MD, Zeijlemaker WP, Van Mourik JA, Van Aken WG. Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells. Exp Cell Res. 1982;139: 191-197.
29. Sixma JJ, Nievelstein PFEM, Zwaginga JJ, De Groot PG. Adhesion of blood platelets to the extracellular matrix of cultured human endothelial cells. Ann N Y Acad Sci. 1987;516:39-51.
30. Sakariassen KS, Aarts PAMM, De Groot PG, Houdijk WPM, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix and purified components. J Lab Clin Med. 1983; 102:522-535.
31. Nievelstein PFEM, d'Alessio PA, Sixma JJ. Fibronectin in platelet adhesion to human collagen types I and III: use of nonfibrillar and fibrillar collagen in flowing blood studies. Arteriosclerosis. 1988;8: 200-206.
32. Beumer S, Ijsseldijk MJW, De Groot PG, Sixma JJ. Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of membrane GP IIb/IIIa and VLA-5 and inhibition by heparin. Blood. 1994;84:3724-3733.
33. Hindriks GA, Ijsseldijk MJW, Sonnenberg A, Sixma JJ, De Groot PG. Platelet adhesion to laminin: role of Ca2+ and Mg2+ ions, shear rate, and platelet membrane glycoproteins. Blood. 1992;79: 928-935.
34. Agbanyo FR, Sixma JJ, De Groot PG, Languino LR, Plow EF, Thrombospondin-platelet interactions: role of divalent cations, wall shear rate and platelet membrane glycoproteins. J Clin Invest. 1993; 92:288-296.
35. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest. 1986; 78:1456-1461.
36. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanahe K, Itagaki I, Sakai, F, Ruggeri ZM. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 1991;87:1234-1240.
37. Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI. von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J Clin Invest. 1991;88:1568-1573.
38. Chow TW, Heliums JD, Moake JL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood. 1992;80:113-120.
39. Voorberg J, Fontijn R, Van Mourik JA, Pannekoek H. Domains involved in multimer assembly of von Willebrand factor (vWF): multimerization is independent of dimerization. EMBO J. 1990;9: 797-803.
40. Sakariassen KS, Ottenhof-Rovers M, Sixma JJ. Factor VIII-von Willebrand factor requires calcium for facilitation of platelet adherence. Blood. 1984;63:996-1003.
41. Aleviadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, McIntire LV. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood. 1993;81:1263-1276.
42. Ruggeri ZM, DeMarco L, Gatti L, Bader R, Montgomery RR. Platelets have more than one binding site for von Willebrand factor. J Clin Invest. 1983;72:1-12.
43. Rand JH, Sussman II, Gordon RE, Shu SV, Solomon V. Localization of factor VIII-related antigen in human vascular subendothelium. Blood. 1980;55:752-756.
44. Sussman II, Rand JH. Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells. J Lab Clin Med. 1982;100:526-532.
45. Rand JH, Patel ND, Schwartz E, Zhou S-L, Potter BJ. 150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J Clin Invest. 1991;88:253-259.
46. Rand JH, Wu X-X, Potter BJ, Uson RR, Gordon RE. Co-localization of von Willebrand factor and type VI collagen in human vascular subendothelium. Am J Pathol. 1993;142:843-850.
47. van Zanten GH, de Graaf S, Slootweg PJ, Heijnen HFG, Connolly TM, de Groot PG, Sixma JJ. Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest. 1994;93:615-632.
48. De Groot PG, Ottenhof-Rovers M, Van Mourik JA, Sixma JJ. Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion to subendothelium is not collagen. J Clin Invest. 1988;82:65-73.
49. Turitto VT, Weiss HJ, Baumgartner HR. Decreased platelet adhesion on vessel segments in von Willebrand's disease: a defect in initial attachment. J Lab Clin Med. 1983;102:551-564.
50. Goldsmith HL, Turitto VT. Rheological aspects of thrombosis and haemostasis: basic principles and applications. Thromb Haemost. 1986;55:415-435.
51. Sobel M, Soler DF, Kermode JC, Harris RB. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem. 1992;267:8857-8862.
52. Sixma JJ, Schiphorst ME, Verweij CL, Pannekoek H. Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin. Eur J Biochem. 1991;196:369-375.
53. Sobel M, McNeill PM, Carlson PL, Kermode JC, Adelman B, Conroy R, Marques D. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. J Clin Invest. 1991;87:1787-1793.
54. Lyons SE, Bruck ME, Bowie EJ, Ginsburg D. Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem. 1992;267:4424-4430.
55. Lankhof H, Wu YP, Schiphorst ME, Zerwes H, De Groot PG, Sixma JJ. Role of the GPIb-binding A1-repeat and the RGD-sequence in platelet adhesion to recombinant von Willebrand factor. Blood. 1995;86:1035-1043.
56. Tschopp TB, Baumgartner HR. Platelet adhesion and mural platelet thrombus formation on aortic subendothelium of rats, rabbits and guinea pigs correlate negatively with the vascular PGI2-production. J Lab Clin Med. 1981;98:402-411.